Psilera Commends Landmark Executive Order Prioritizing Psychedelic Therapies

TAMPA, Fla., April 20, 2026 /PRNewswire/ -- Psilera, a leading biopharmaceutical company pioneering next-generation psychedelics and neuroplastogens, today issued a statement of strong support for the Executive Order signed on April 18, 2026. The order, titled "Accelerating Medical...